68Ga-grazytracer PET for noninvasive assessment of response to immunotherapy in solid tumors and lymphomas: a phase 1/2 clinical trial
Xiuling Shen(Peking University), Nan Li(Peking University Cancer Hospital)
Cited by 23
Related Papers
First-in-Humans Evaluation of a PD-L1–Binding Peptide PET Radiotracer in Non–Small Cell Lung Cancer Patients
|Journal of Nuclear Medicine|2021|129